Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 12, No 3 (2016) CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY Abstract  PDF (Eng)  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko
"... that are sensitive or resistant to acetylsalicylic acid (ASA) before and after coronary artery bypass graft (CABG ..."
 
Vol 12, No 5 (2016) Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome Abstract  similar documents
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova
"... in acetylsalicylic acid (ASA) sensitive and resistant patients with acute coronary syndrome (ACS). Material ..."
 
Vol 9, No 3 (2013) RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION Abstract  similar documents
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova, I. E. Deneka
"... A new method of non-drug treatment of resistant hypertension – renal denervation is considered ..."
 
Vol 11, No 3 (2015) RENAL DENERVATION IN THE TREATMENT OF RESISTANT HYPERTENSION: RESULTS OF A ONE-YEAR OBSERVATIONAL STUDY Abstract  similar documents
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova
"... and vegetative status in patients with resistant hypertension (HT). Material and methods. Patients ..."
 
Vol 12, No 2 (2016) RESISTANT HYPERTENSION: THE AWARENESS OF DOCTORS AND THE EFFECTIVENESS OF THE COMBINATION THERAPY Abstract  similar documents
R. R. Kushkhova, A. G. Avtandilov, A. A. Pukhaeva
"... Aim. To study the doctor awareness of the criteria of resistant hypertension (RHT) and to evaluate ..."
 
Vol 12, No 4 (2016) Resistant hypertension: epidemiology and risk factors Abstract  similar documents
I. E. Deneka, A. A. Svetankova, A. V. Rodionov
"... modifiable causes of resistant hypertension, that are often underestimated, are considered: obesity ..."
 
Vol 12, No 4 (2016) Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension Abstract  similar documents
R. R. Kushkhova, A. G. Avtandilov
"... hemodynamics in patients with drug resistant hypertension (HT). Material and methods. In total, 120 patients ..."
 
Vol 15, No 4 (2019) Resistant Hypertension: Questions and Contemporary Answers Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, K. K. Osadchiy
"... The review presents the important problem of resistant hypertension. Its real prevalence ..."
 
Vol 12, No 6 (2016) RESISTANT HYPERTENSION IN A PATIENT WITH METABOLIC SYNDROME Abstract  similar documents
O. M. Drapkina, J. S. Sibgatullina
"... Clinical case of resistant hypertension in a patient with metabolic syndrome is presented ..."
 
Vol 11, No 2 (2015) RESISTANT ARTERIAL HYPERTENSION: IS THE CONSENSUS BETWEEN CONSERVATIVE AND INTERVENTIONAL THERAPY POSSIBLE? Abstract  similar documents
Yu. I. Grinshtein, V. V. Shabalin
"... Resistant hypertension is defined as hypertension uncontrolled with optimal doses of three ..."
 
Vol 11, No 6 (2015) Nephrogenic factors of resistance to antihypertensive treatment in patients with essential hypertension Abstract  similar documents
N. V. Teplova, V. A. Lyusov, R. G. Oganov, E. M. Evsikov, R. A. Sharipov, M. H. Zhapoeva, E. G. Kurumlidu
"... and progression of primary arterial hypertension (HT) resistant to combination antihypertensive therapy (AHT ..."
 
Vol 4, No 2 (2008) ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov
"... ,05). The incidence of early complications of acute myocardial infarction is higher in patients resistant to ASA ..."
 
Vol 5, No 6 (2009) RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID Abstract  similar documents
N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
"... ,6% among ASA sensitive patients and 50% - among ASA resistant patients. Repeated atherothrombotic events ..."
 
Vol 7, No 4 (2011) ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID Abstract  similar documents
I. N. Bokarev, L. V. Popova
"... An experience of acetylsalicylic acid (ASA) clinical use since its synthesis in 1887 ..."
 
Vol 12, No 4 (2016) High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice Abstract  similar documents
N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
"... analysis. The risk of myocardial infarction or unstable angina pectoris in the ASA-resistant patients ..."
 
Vol 5, No 3 (2009) ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva
"... induction was considered as criterion of resistance to emASA/em. Patients were considered as emresistant/em, partly ..."
 
Vol 3, No 4 (2007) RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi
"... sensitivity to acetylsalicylic acids (emASA/em) in patients with stable angina. Material and methods. 96 patients ..."
 
Vol 15, No 3 (2019) Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery Abstract  similar documents
A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein
"... with acetylsalicylic acid (emASA/em) resistance in patients with coronary heart disease after coronary bypass surgery (emCABG/em ..."
 
Vol 6, No 2 (2010) REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT Abstract  similar documents
A. N. Britov, M. M. Bystrova
"... emРезистентную/em артериальную гипертонию (АГ) диагностируют, если при приеме трех антигипертензивных ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... Use of acetylsalicylic acid (emASA/em) in cardiology practice is presented. emASA/em modes of action ..."
 
Vol 8, No 2 (2012) EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva
"... Acetylsalicylic acid (emASA/em) use in the primary and secondary prevention of cardiovascular diseases ..."
 
Vol 8, No 4 (2012) ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? Abstract  similar documents
I. V. Zhirov
"... The results of recent trials on acetylsalicylic acid (emASA/em) efficacy are presented. Data ..."
 
Vol 9, No 4 (2013) ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES Abstract  similar documents
E. N. Dankovtseva
"... Review of current ideas about the role of acetylsalicylic acid (emASA/em) in the primary prevention ..."
 
Vol 8, No 2 (2012) ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS Abstract  similar documents
A. V. Govorin, A. P. Filev
"... of acetylsalicylic acid (emASA/em) in primary and secondary prevention of atherothrombotic events. Studies on the safety ..."
 
Vol 5, No 4 (2009) GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY Abstract  similar documents
A. L. Komarov
"... Lesion of gastrointestinal mucous coat is the main factor limited acetylsalicylic acid (emASA/em) use ..."
 
Vol 7, No 5 (2011) THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman
"... . Complex therapy (acetylsalicylic acid (emASA/em), beta-blockers (BB), ACE inhibitors, statins) was prescribed ..."
 
Vol 8, No 1 (2012) RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
V. A. Sulimov, E. V. Moroz
"... to subgroups of clopidogrel sensitive or emresistant/em depending on platelet aggregation. In emresistant/em subgroup ..."
 
Vol 4, No 1 (2008) COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich
"... .o. were included in the study. They took investigated emASA/em medicines one after another during 4 weeks each ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... acetylsalicylic acid (emASA/em) in patients with high cardiovascular risk. Material and мethods. Patients (n=30 ..."
 
Vol 8, No 2 (2012) RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS Abstract  similar documents
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova
"... Aim. To compare effects of acetylsalicylic acid (emASA/em) and two clopidogrel drugs on residual ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... that  risk associated with acetylsalicylic acid (emASA/em) use in patients ≥75 years can overweigh its potential ..."
 
Vol 9, No 3 (2013) TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN Abstract  similar documents
A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin
"... emрезистентными/em к emАСК/em, так как время крово- течения увеличилось меньше чем на два стандартных квадратичных ..."
 
Vol 13, No 2 (2017) ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE Abstract  similar documents
V. I. Podzolkov, N. A. Dragomiretskaya
"... , in treatment of such conditions as primary hyperaldosteronism, emresistant/em hypertension, edematous syndrome ..."
 
Vol 12, No 5 (2016) Arterial Hypertension in Patients with Rheumatoid Arthritis. What should be known and considered at diagnosis and treatment? Abstract  similar documents
N. M. Nikitina, T. A. Romanova, I. A. Afanas'ev, M. A. Tyapkina, A. P. Rebrov
"... patients with RA 7.5% of patients had emresistant/em HT, 36.8% - do not regularly control BP. During daily ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... as a drug of choice from the P2Y12 inhibitor group, the use of low doses of acetylsalicylic acid (emASA/em ..."
 
Vol 9, No 1 (2013) POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova
"... and induced flow cytofluorometry during antiplatelet therapy with clopidogrel and acetylsalicylic acid (emASA/em ..."
 
Vol 3, No 3 (2007) RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
"... , emрезистентно/em- сти к emАСК/em может иметь полиморфизм генов тромбоци- тарных рецепторов к коллагену и фактору ..."
 
Vol 8, No 1 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... . Despite progress in treatment of this disease, a number of people with uncontrolled or emresistant/em HT ..."
 
Vol 8, No 2 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... . Despite progress in treatment of this disease, a number of people with uncontrolled or emresistant/em HT ..."
 
Vol 4, No 3 (2008) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION Abstract  similar documents
A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk
"... with ischemic heart disease (IHD) before and after coronary artery bypass graft (emCABG/em). Material and methods ..."
 
Vol 6, No 4 (2010) CLOPIDOGREL PHARMACOGENETICS Abstract  similar documents
A. N. Meshkov
"... insufficient effect in some patients, ie they are emresistant/em to clopidogrel. Genetic causes of resistance ..."
 
Vol 15, No 4 (2019) Antimicrobial Treatment of Infective Endocarditis, Caused by Enterococcus Faecalis Abstract  PDF (Eng)  similar documents
E. V. Shikh, T. E. Morozova, V. N. Drozdov, N. B. Lazareva, D. A. Shatsky, T. B. Andrushchyshina, M. V. Lukina, O. A. Vartanova
"... are the main drugs of treating infective endocarditis caused by vancomycin-emresistant/em enterococci. Native ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
"... patients that are emresistant/em to clopidogrel (PRU208) and in patients with a normal response to clopidogrel ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... therapy (DAT) com- prised of acetylsalicylic acid (emASA/em) and one of P2Y12-receptor blockers ..."
 
Vol 10, No 6 (2014) THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY Abstract  similar documents
D. A. Andreev
"... ослож- нения, связанные с тромбозом, дал повод выделять больных, emрезистентных/em к emАСК/em. Частота ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
"... (emАСК/em) в кардиологической практике. Особое внимание уделяется дженерическим препаратам emАСК/em, применение ..."
 
Vol 5, No 5 (2009) EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi
"... ацетилсалициловой кислотой (emАСК/em), клопидогрелом и комбинированной антиагрегантной терапии (emАСК/em + клопидогрел ..."
 
Vol 15, No 4 (2019) Atrial Septal Aneurysm in Adult Patients of Therapeutic Hospital Abstract  similar documents
O. V. Ryazantseva, N. I. Lenkova, O. D. Ostroumova, E. V. Shikh, S. M. Rykova
"... Aim. To study detection of atrial septal aneurysm (emASA/em) by transthoracic echocardiography ..."
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
"... , Post-emCABG/em, TNT) and meta-analyzes on the role of statins, prescribed before and after coronary artery ..."
 
Vol 14, No 5 (2018) Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting Abstract  similar documents
A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash
"...   artery bypass grafting (emCABG/em). Material and methods. 347 CAD patients who underwent emCABG/em in the period ..."
 
Vol 13, No 3 (2017) ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING Abstract  similar documents
A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya
"... with ischemic heart disease during a coronary artery bypass surgery (emCABG/em). Material and methods. The study ..."
 
Vol 2, No 3 (2006) CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES Abstract  similar documents
P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian
"... или инсультов по сравнению с пациентами, чувствительными к аспирину. Так, среди emрезистентных/em к ..."
 
Vol 11, No 5 (2015) Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease Abstract  similar documents
O. A. Rubanenko
"... ) development after coronary artery bypass graft (emCABG/em) surgery in patients with ischemic heart disease (IHD ..."
 
Vol 7, No 3 (2011) STROKE PREVENTION IN INTERNIST PRACTICE Abstract  similar documents
D. A. Napalkov, A. V. Zhilenko
"... аце- тилсалициловой кислоты (emАСК/em) для вторичной про- филактики сердечно-сосудистых событий изучено до ..."
 
Vol 6, No 2 (2010) THE MODERN ASPECTS OF CLOPIDOGREL USE Abstract  similar documents
E. N. Dankovtseva, D. A. Zateyshchikov
"... (emрезистентные/em к emАСК/em), а у 76 % (n=38) пони- зилась в 3 раза (чувствительные к emАСК/em). Таким образом, при лечении ..."
 
Vol 13, No 1 (2017) MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya
"... % 100 80 60 40 20 0 No CA / Без КАГ After CA / После КАГ emASA/em emАСК/em Clopidogrel Клопидогрел ..."
 
Vol 5, No 2 (2009) THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY Abstract  PDF (Eng)  similar documents
O. V. Reshetko, N. V. Furman, R. M. Magdeev
"... - sent in 4.9% of CDH patients and 5.8% of MH patients. Acetylsalicylic acid (emASA/em) as well as its ..."
 
Vol 6, No 1 (2010) ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... - мендован прием ацетилсалициловой кислоты (emАСК/em), при среднем риске (1-2 балла) уже целесообразно на ..."
 
Vol 14, No 6 (2018) Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 Abstract  PDF (Eng)  similar documents
V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova
"... subgroups: salt-sensitive (group 1) and salt-emresistant/em (group 2), and then randomized to subgroups A and B ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... сравнению с 2006 г. emASA/em - acetylsalicylic acid / emАСК/em – ацетилсалициловая кислота emASA/em emАСК/em Dipyridamole ..."
 
Vol 14, No 4 (2018) Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, K. Bates, E. A. Goryachkin, N. Bobrova, L. I. Syromiatnikova, Yu. V. Popova, D. Yu. Platonov, I. V. Osipova, A. M. Nedbaikin, T. N. Malorodova, O. A. Mirolyubova, D. V. Kryuchkov, L. A. Khaisheva, A. S. Galyavich, M. V. Franz, A. Yu. Efanov, D. V. Duplyakov, O. M. Drapkina, D. Leon, M. McKee
"... PCI, and 2.2% emCABG/em. Turning to cardiovascular risk factors, 46.2% of patients smoked prior ..."
 
Vol 13, No 1 (2017) THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY) Abstract  PDF (Eng)  similar documents
S. А. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, N. P. Kutishenko, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, E. V. Kudryashov, A. D. Deev
"... often, preparations of acetylsalicylic acid (emASA/em) – 2 times, ACE inhibitors – 6 times and anticoagulants ..."
 
Vol 12, No 3 (2016) ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER) Abstract  PDF (Eng)  similar documents
Yu. V. Lukina, N. A. Dmitrieva, A. V. Zakharova, A. V. Zagrebelnyy, N. P. Kutishenko, S. Yu. Martsevich
"... / ИАПФ, 15,0% Warfarin / Варфарин, 3,7% emASA/em / emАСК/em, 14,7% Others / Другие, 14,7%CCB / АК, 11 ..."
 
Vol 7, No 4 (2011) COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) Abstract  similar documents
O. V. Dralova, M. L. Maksimov
"... A.V. emResistant/em and uncontrolled hypertension in the Russian Federation: epidemiological ..."
 
Vol 10, No 2 (2014) ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Maslakov
"... - титромбоцитарных препаратов лидирует ацетилсали- циловая кислота (emАСК/em), которая назначается в виде мо- нотерапии ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF ACIDUM ACETYLSALICYLICUM USAGE Abstract  similar documents
V. N. Drozdov, V. A. Kim
"... ): vndrozdov@yandex.ru С 1899 г ацетилсалициловая кислота (emАСК/em) под тор- говым названием «Аспирин» начала ..."
 
Vol 8, No 4 (2012) COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»  similar documents
D. V. Nebieridze
"... тромбоцитов к NO (р0,01) отмечалось в когорте па- циентов, изначально emрезистентных/em к NO. Результаты обо- их ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... ): izhirov@mail.ru Введение Ацетилсалициловая кислота (emАСК/em) — лекарственный препарат, ставший легендой ..."
 
Vol 10, No 6 (2014) PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION Abstract  similar documents
N. V. Mikheeva, O. V. Reshetko, N. V. Furman
"... современным рекомендациям [AHA/emASA/em(2007- 2011);ESO(2008); национальное руководство по неврологии под ред ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... время при- сутствовали ацетилсалициловая кислота (emАСК/em) и анта- гонисты витамина К (АВК) — варфарин ..."
 
Vol 9, No 5 (2013) CLINICAL IMPORTANCE OF ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. N. Kushnarenko, A. V. Govorin
"... ) was calculated. Patients with HOMA- IR2.77 were considered as insulin-emresistant/em. Results. Patients with gout ..."
 
Vol 9, No 2 (2013) PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET Abstract  similar documents
L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova
"... as decrease in anemia emresistant/em to the action of erythropoiesis-stimulating agents) were found after ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... , варфарина или плацебо, также все участники получали небольшие дозы ацетилсалициловой кислоты (emАСК/em; 81 мг в ..."
 
Vol 5, No 3 (2009) CONTEMPORARY PROBLEMS OF EVALUATION OF HYPERTENSION TREATMENT EFFICACY: MASKED HYPERTENSION AND WHITE COAT HYPERTENSION Abstract  similar documents
V. M. Gorbunov, M. I. Smirnovа
"... «emрезистентной/em» или «рефрактерной» АГ можно говорить в том случае, когда, несмотря на прием трех и более ..."
 
Vol 13, No 2 (2017) RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY Abstract  similar documents
. Editorial
"... кислотой (emАСК/em) у пациентов, завершивших основной курс антикогулянтной тера- пии тромбоза глубоких вен (ТГВ ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... ацетилсалициловая кислота (emАСК/em) – дезагрегант пер- вого поколения, антитромбоцитарные свойства кото- рого впервые ..."
 
Vol 9, No 4 (2013) THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev
"... клопидогрел (75 мг)+ацетилсалициловую кислоту (emАСК/em) (75- 325 мг), либо только emАСК/em (75-325 мг) на срок от 9 до ..."
 
Vol 8, No 4 (2012) RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS  similar documents
S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz
"... выбрали когорту боль- ных, более emрезистентных/em к NO, путем исключения па- циентов с исходным ответом на НПН ..."
 
Vol 13, No 3 (2017) ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION Abstract  similar documents
F. I. Belyalov
"... ацетилсалициловой кислоты (emАСК/em) у пациентов со стабильной ИБС или высоким риском ИБС и комор- бидной ХБП снизило ..."
 
Vol 7, No 2 (2011) PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? Abstract  similar documents
I. V. Zotova, D. A. Zateyshchikov
"... ацетилсалициловой кислоты (emАСК/em) сопро- вождается снижением риска развития ССО. В крупном проспективном ..."
 
Vol 9, No 6 (2013) ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? Abstract  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein
"... - фекта ацетилсалициловой кислоты (emАСК/em) и Р2Y12 ин- гибиторов, а также выявление взаимосвязи остаточной ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... (emАСК/em) в качестве средства профилактики тромбоэмболических осложнений у пациентов с ФП ре- комендуется ..."
 
Vol 5, No 5 (2009) ANTIAGGREGANT THERAPY OVERCOMES LIMITS Abstract  similar documents
I. Andreeva
"... частности, было пока- зано, что клопидогрел в сочетании с ацетилсалициловой кислотой (emАСК/em) улучшает перфузию ..."
 
Vol 13, No 3 (2017) DRUG TREATMENT OF PATIENTS WITH THE HISTORY OF ACUTE STROKE: DATA OF THE PILOT PHASE OF THE OUTPATIENT REGISTRY «REGION» Abstract  similar documents
S. A. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, A. D. Deev
"... / Регистр ОНМК-ЛД (n=44) emASA/em / emАСК/em AS-FA registry - registry of acute stroke of the %rst apply; AS-AR ..."
 
Vol 2, No 2 (2006) METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS Abstract  similar documents
N. V. Perova, I. N. Ozerova, V. A. Metelskaya
"... процент боль- ных, emрезистентных/em к такой терапии; обычно у них от- мечают низкий уровень ХС ЛПВП. Если ..."
 
Vol 5, No 6 (2009) RESULTS OF THE CONTROL RANDOMIZED STUDIES IN 2009: WHAT IS NEW IN CARDIOLOGY Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina
"... показано, что так называемая двойная анти- агрегантная терапия (ацетилсалициловая кислота, emАСК/em плюс ..."
 
Vol 10, No 1 (2014) ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES Abstract  similar documents
J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili
"... emрезистентной/em АГ, возможно, за счет прямого воздействия на арте- риальную жесткость [33]. Восполнение ..."
 
Vol 6, No 6 (2010) THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS Abstract  similar documents
Yu. A. Bunin
"... не влияли на неё при ХСН III ФК emCABG/em-PATCH [28] КШ и КШ плюс ИКД ИБС; ФВЛЖ36% и поздние потенциалы ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... пациентам значи- тельно чаще рекомендовали прием ацетилсалицило- вой кислоты (emАСК/em; 76,02% против 68,51% для ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... (emАСК/em), как средства профилактики тромбоэмболических ослож- нений при ФП. emАСК/em практически не снижает ..."
 
Vol 10, No 5 (2014) DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE Abstract  similar documents
G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov
"... кислоты (emАСК/em) и клопи- догрела рассматривается как обязательный элемент профилактики тромбообразования у ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... использования ацетилсалициловой кислоты (emАСК/em) в качестве средства профилактики тромбоэмболических осложнений у ..."
 
Vol 9, No 6 (2013) PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE Abstract  similar documents
P. V. Dolotovskaya, E. Y. Rudnichenko, N. V. Furman, O. V. Reshet'ko
"... склонны назначать основные пре- параты для терапии ИБС [ацетилсалициловую кислоту (emАСК/em), бета ..."
 
Vol 7, No 5 (2011) DYNAMICS OF ACUTE CORONARY SYNDROME PATIENT MANAGEMENT IN NONIVASIVE PRIMARY VASCULAR CENTER (ACCORDING TO RECORD AND RECORD-2 REGISTERS) Abstract  similar documents
V. M. Provotorov, I. Shevchenko, R. Islamov
"... ре- комендованных препаратов (рис. 2). Прием препара- тов ацетилсалициловой кислоты (emАСК/em) пациентами ..."
 
Vol 6, No 2 (2010) IN THE ISSUE Abstract  similar documents
"... профилактики внезапной смерти у больных с систолической дисфункцией левого же- лудочка. emРезистентная/em АГ ..."
 
Vol 8, No 5 (2012) RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE Abstract  similar documents
I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman
"... больных фибрилляцией предсердий Проводимая терапия Все пациенты ПФП РФП 0 баллов emАСК/em, n (%) 14 (100) 0 ..."
 
Vol 7, No 5 (2011): ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ЛЕКАРСТВЕННОЙ ТЕРАПИИ ПРИ ПЕРВИЧНОЙ И ВТОРИЧНОЙ ПРОФИЛАКТИКЕ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ. РЕКОМЕНДАЦИИ ВНОК, 2011 Abstract  similar documents
, , , , , , , ,
"... – аланинаминотрансфераза АПФ – ангиотензинпревращающий фермент АРА – антагонисты рецепторов ангиотензина II emАСК/em ..."
 
Vol 11, No 5 (2015) Subscription to the journal Abstract  similar documents
article Editorial
"... эндопротезировании крупных суставов Ренальная денервация в лечении emрезистентной/em артериальной гипертензии Омега-3 ..."
 
Vol 4, No 2 (2008) EDITORIAL Abstract  similar documents
статья Редакционная
"... emрезистентных/em к ацетил- салициловой кислоте и клопидогрелю больных достоверно выше частота ранних осложнений ..."
 
Vol 7, No 3 (2011) MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko
"... котором было продемонстрировано, что ацетилсалициловая кислота (emАСК/em), назначаемая в первые часы острого ин ..."
 
1 - 100 of 211 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)